Close
Smartlab Europe
Inizio Ignite
Production & Manufacturing

ADIENNE Pharma signs manufacturing deal with Selexis

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

BioPharma

Injectable Drug Formulation Trends in Biopharma

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.
Drug Research

Advancing Drug Formulation Stability in Modern Pharma

Exploration of the chemical, physical, and environmental factors that compromise the integrity of modern therapeutics, and the advanced testing protocols used to ensure safety.
Drug Research

Lipid-Based Drug Delivery System for Low-Soluble Drugs

Detailed review of how lipidic excipients and nano-emulsified systems are utilized to enhance the absorption and bioavailability of hydrophobic pharmaceutical compounds.
- Advertisement -

ADIENNE Pharma & Biotech has signed a service agreement with Selexis for the development of a manufacturing cell line for one of the ADIENNE’s orphan drugs.

Selexis CEO Igor Fisch said, “Combining our expertise in difficult-to-express proteins with our SUREtechnology Platform(TM) is an important step in advancing ADIENNE’s project to the clinic.”

ADIENNE Pharma & Biotech founder and CEO Antonio Francesco Di Naro said Selexis expertise will be an added value for the company’s molecule.

Selexis is a global life sciences company for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins.

Latest stories

Previous article
Indian state plans non-generic drugs procurement for government hospitals
Next article
Clarity Pharmaceuticals, Dalton Pharma sign manufacturing services contract

Related stories

BioPharma

Injectable Drug Formulation Trends in Biopharma

Analysis of the evolving landscape of parenteral delivery, focusing on the stability of high-concentration biologics and the integration of patient-centric delivery devices.
Drug Research

Advancing Drug Formulation Stability in Modern Pharma

Exploration of the chemical, physical, and environmental factors that compromise the integrity of modern therapeutics, and the advanced testing protocols used to ensure safety.
Drug Research

Lipid-Based Drug Delivery System for Low-Soluble Drugs

Detailed review of how lipidic excipients and nano-emulsified systems are utilized to enhance the absorption and bioavailability of hydrophobic pharmaceutical compounds.
Drug Research

Formulation Strategies for Improving Drug Bioavailability

Analysis of the chemical and physical methodologies employed to overcome solubility and permeability barriers, ensuring active pharmaceutical ingredients reach systemic circulation effectively.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

About us

World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives. . . Read More

SUBSCRIBE US

System

RESOURCES

ARCHIVE LINKS

Subscribe

Copyright © 2010-2026 World Pharma Today. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »
MORE STORIES
injectable drug formulation trends

Injectable Drug Formulation Trends in Biopharma

ACG Packaging Materials

ACG Packaging Materials Joins WEF Global Lighthouse Network